Drug intelligence / Profile preview

sodium feredetate + ascorbic acid

Development stage
Unknown
Lead developer
Martin Dow
Modality
Small Molecules
Administration
Oral
01

Overview

Sodium feredetate + ascorbic acid is a fixed-dose combination iron supplement used for the treatment and prevention of iron deficiency anemia. Sodium feredetate (sodium iron EDTA) is a stable chelated form of iron(III) that protects the iron from precipitating or binding to dietary inhibitors such as phytates and polyphenols in the gastrointestinal tract. This chelation enhances iron bioavailability, particularly in diets high in plant-based inhibitors, and is associated with a lower incidence of gastrointestinal side effects like constipation and nausea compared to traditional ferrous salts. Ascorbic acid (Vitamin C) is included to further enhance iron absorption by acting as a reducing agent, maintaining iron in its more soluble ferrous (Fe2+) state and facilitating its uptake via the divalent metal transporter 1 (DMT1) in the duodenal mucosa.

Brand names
Fero-CFero-C Plus
Other names
sodium iron ethylenediaminetetraacetic acid + ascorbic acidsodium iron EDTA + ascorbic acidsodium iron ethylenediaminetetraacetate + vitamin Csodium feredetate + vitamin C
02

Targets

SLC11A2 (DMT1)

Beyond the preview

Go deeper on sodium feredetate + ascorbic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium feredetate + ascorbic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call